It's a $45 billion market -- here are some winners that could keep winning.
News & Analysis: Provention Bio Inc
Seven biotechs led the way.
There are some highly promising diabetes treatments entering the market that investors should know about.
These biotech stocks have at least quadrupled in just over six months this year.
These three diabetes stocks have a lot going on this month.